Comunicazioni a congressi internazionali (periodo 2000-1995)
1. L.S. Malatino, F. Mallamaci, A. Cataliotti, I. Bellanuova, F. Benedetto, R. Tripepi,
G. Tripepi, S. Parlongo, C. Zoccali. Circulating E-selectin and left ventricular
concentric hypertrophy-remodeling in and stage renal-failure. 18° Congress of
International Society of Hyperyension, Chicago, 20-24 Aug 2000.
2. C. Zoccali, F. Benedetto, F. Mallamaci, G. Tripepi. Left ventricular hypertrophy
and nocturnal hypoxemia in dialysis patients. 18° Congress of International
Society of Hyperyension, Chicago, 20-24 Aug 2000.
3. F. Mallamaci, F. Cuzzola, S. Parlongo, G. Tripepi, C. Zoccali. Smoking and renal
risk in patients with mild to moderate essential hypertension. 18° Congress of
International Society of Hyperyension, Chicago, 20-24 Aug 2000.
4. C. Zoccali, A. Testa, B. Spoto, V. Misefari, A. Perna,R. Benini,P. Ruggenenti,G.
Remuzzi. Alpha-adducin gene polymorphism and renal disease progression. 18°
Congress of International Society of Hyperyension, Chicago, 20-24 Aug 2000.
5. F. Galletti, C. Zoccali, F. Mallamaci, A. Barbato, P. Strazzullo. Evaluation of
intravenous Naci load as a test of salt sensitivity in essential hypertensive
patients. 10° European Meeting on Hypertension. Goteborg, 29 May-30 June
2000.
6. F. Galletti, C. Zoccali, F.Mallamaci, A.Barbato, P. Strazzullo. Heterogeneity of
blood pressure response to volume expansion and depletion manoeuvre during
the grim test of salt-sensitivity. 10° European Meeting of Hypertension. Goteborg
29 May-30 June 2000.
7. F. Mallamaci, F. Cuzzola, G. Caridi, F. Marino, C. Zoccali. Salt-sensitivity does
not implicate nocturnal hypertension. 10° European Meeting on Hypertension.
Goteborg, Sweden 29 May-30 June 2000.
8. C. Zoccali, S. Boeger, F. Mallamaci, FA. Benedetto, G. Tripepi, L. Malatino,
R.Boeger. Asymmetric dimethylarginine (ADMA) is related to the severity of
atherosclerosis and predicts mortality in end stage renal failure (ESRF). 10°
European Meeting on Hypertension. Goteborg, Sweden 29 May-30 June 2000.
9. C. Zoccali, B. Spoto,A. Testa,G. Romeo,V. Misefari,A. Perna,R. Benini,P.
Ruggenenti, G. Remuzzi (GISEN-GROUP). Alpha-adducin polymorphism and renal
disease progression. 37° Congress EDTA-ERA. Nice, 17-20 September 2000.
10. G.Enia, F.Mallamaci, FA Benedetto, E. Cottini, G. Tripepi, S. Cutrupi, S.
Parlongo, C. Zoccali et al. CAPD patients on long term treat are volume expanded
and display more severe left ventricular hypertrophy than hemodialysis patients.
37° Congresso EDTA-ERA, Nice 17-10 September 2000.
11. C. Zoccali. Inflammation, asymetric dimethylarginine and atherosclerosis in
dialysis patients. (Mini lecture). 36° Congress EDTA-ERA. Nice, 17-20 September
2000.
12. F. Mallamaci,K. Asahi, FA Benedetto, G, Tripepi, R. Tripepi, T. Miyata,
C. Zoccali. Pentosidine and left ventricular geometry in dialysis patients. 36°
Congress EDTA-ERA. Nice, 17-20 September 2000.
13. C. Zoccali. "Disability" in dialysis patients. 18° Annual Meeting of the
International Society of Blood Purification. Roma, 6-8 September 2000 (lettura su
invito).
14. C. Zoccali. Renin-Angiotensin System Genes and the response to ACE Inhibitors
in Chronic Nephropathies. Genetics of Hypertension: Approaches, Paradigms and
Impact. Porto Cervo, 30 September- 1 October 2000 (lettura su invito).
15. F. Mallamaci, FA Benedetto, G. Bonanno, G. Tripepi, S. Parlongo, S. Cutrupi, P.
Fatuzzo, F.Rapisarda, LS Malatino, C. Zoccali. Cardiac Natriuretic Peptides are
related to Left Ventricular Mass and Ejection Fraction and predict mortality in
Dialysis Patients. ASN 2000.
16. C. Zoccali,F. Mallamaci, S.Bode Boger, FA Benedetto, G. Tripepi, L. Malatino, R.
Boger. Asymmetric Dimethylarginine (ADMA): an endogenous inhibitor of no
syntase is related to the severity of atherosclerosis and predict mortality in ESRD.
ASN 2000.
17. F. Mallamaci, F. Cuzzola, S. Parlongo, G. Tripepi, C. Zoccali. The renal risk of
smoking in essential hypertension. 33° ASN Annual Meeting. Toronto, Canada 10-
16 October 2000.
18. C.Zoccali. Cardiovascular problems in chronic renal failure. Kidney> success after
failure update across the Millenium. The Jubilee in Rome. Roma, 3-4 Novembre
2000. (lettura su invito)
19. C. Zoccali, G. Tripepi. Cohort and case control studies. Biostatistics and
Epidemiology Course. Gdansk, Polonia, 10-11 Novembre 2000.
20. C. Zoccali. A critical view from the clinician. VII Simposio Internacional Instituto
"Reina Sofia" de la fundacion renal. Madrid, 16-17 Novembre 2000.
21. C. Zoccali. Pathophysiology and risk factors. VII Simposio Internacional Instituto
"Reina Sofia" de la fundacion renal. Madrid, 16-17 Novembre 2000.
22. C. Zoccali. Evidence, Quality and Costs. International Symposium on "The
Challenge in ESRD treatment for the near future”. Perugia, 19-22 June 1999.
(lettura su invito)
23. C. Zoccali, FA. Benedetto, LS.Malatino, F.Mallamaci, G.Tripepi and CREED
investigators. Left ventricular mass is a major determinant of plasma natriuretic
peptides in patients with chronic renal failure. Ninth European Meeting of
Hypertension, Milan 11-15 June 1999.
24. F.Cuzzola, F. Mallamaci, G. Tripepi, S. Parlongo, A. Cataliotti, L.S. Malatino,
C. Zoccali et al. Renal excretion of adrenomedullin is strongly influenced by salt
intake and it is tightly linked to endothelin-1 in patients with essential
hypertension. Ninth European Meeting of Hypertension, Milano 11-15 June 1999.
25. F.Mallamaci, F. Cuzzola, G. Tripepi, S. Cutrupi, S. Parlongo,R. Tripepi, C. Zoccali.
Gender dependent differences in plasma leptin in essential hypertension. Ninth
European Meeting of Hypertension Milano, 11-15 June 1999.
26. L.S. Malatino, G. Tripepi, FA. Benedetto, F. Mallamaci, C. Marino, M. Garozzo,
C. Zoccali et al. Humoral and hemodynamic correlates of hepatocyte growth factor
in end stage renal disease. Fourt Scientific Meeting of American Society of
Hypertension. Buenos Aires 20-22 May 99.
27. F. Mallamaci, F. Cuzzola, G. Tripepi, S.Parlongo, C. Zoccali. Renal excretion of
adrenomedullin is strongly influenced by salt intake and it is tightly linked to
endothelin-1 in patients with mild to moderate essential hypertension. 36°
Congress of EDTA-ERA. Madrid,5-8 September 1999.
28. F.Mallamaci, F.Cuzzola, G. Tripepi, S. Cutrupi, S. Parlongo, C. Zoccali. Sexdependent functional correlations of plasma leptin in human hypertension. 36°
Congress EDTA-ERA. Madrid, 5-8 September 1999.
29. A.Testa,B.Spoto,A.Perna,P.Ruggenenti,R.Benini,G.Romeo,V.Misefari,G.Remuzzi,C.
Zoccali. ACE-Genotype and ACE-Inhibitors induced reno-protection in chronic
proteinuric nephropaties. 36° Congress EDTA-ERA. Madrid,5-8 Sept 1999.
30. F.Mallamaci, FA.Benedetto, G.Tripepi, G.Bonanno,V. Candela, S. Cutrupi, M.
Postorino, S. Parlongo,R.Tripepi,L.Malatino,C. Zoccali.Left ventricular mass and
cardiac natriuretic peptides in patients with chronic renal failure. 36° Congress
EDTA-ERA. Madrid,5-8 Sept 1999.
31. A.Perna, C. Zoccali, S. Ferrari, L. Del Priore, D. Cattaneo, R. Pisoni,L. Mosconi,
A.Testa, G.Remuzzi. Among patients with Proteinuric Chronic Nephropathies,
gender and ACE genotype identify responders to ACE inhibitions. 32° ASN
Meeting, Miami 1-8 November 1999.
32. C. Zoccali, F. Mallamaci, G. Tripepi, F.A.Benedetto, V.Panuccio, V.Candela,
M.Garozzo, S.Cutrupi, S.Parlongo, R.Tripepi, C.Marino, L.Malatino. C Reactive
protein predicts progression af atherosclerosis and mortality in dialysis patients.
32° ASN meeting Miami,1-8 November 1999.
33. G. Enia, G. Tripepi, F. Mallamaci, F.A. Benedetto, G.Bonanno, V.Candela,
S.Cutrupi, M.Postorino, S.Parlongo, R.Tripepi, L.Malatino, C. Zoccali. CAPD
patients are volume expanded and display more sevre LVH than hemodialysis
patients. 32° ASN meeting Miami,1-8 November 1999.
34. F.Mallamaci, F.A.Benedetto, G.Tripepi, V.Candela, S.Cutrupi, M.Postorino,
S.Parlongo, R.Tripepi, L.Malatino, C. Zoccali. Cardiac natriuretic peptides in
dialysis patients are strongly linked to left ventricular mass. 32° ASN meeting
Miami,1-8 November 1999.
35. P. Manunta, P. Stella, CREED Inv., D. Ciurlino,G .Bigatti,E. Messaggio,
L.Malatino, C. Zoccali, G.Bianchi. Ouabain-Like factor and Left Ventricular
Hypertrophy in end stage renal disease. 32° ASN meeting Miami,1-8 November
1999.
36. C. Zoccali. Renoprotection and ACE-Genotype in chronic nephropathies.The 2°
Japanese-European Nephrology Forum, Vibo Valentia 25-27 November 1999.
(lettura su invito)
37. A.Cataliotti, LS Malatino, S. Parlongo, C. Zoccali, et. al. Relationship between
Natriuretic peptides and cardiac mass and ejection fraction in dialysis patients.
72° Scientific Sessions American Heart Association - Novembre 1999.
38. F. Mallamaci, A.Zuccalà, R. Gaggi, M. Misefari, F. Cuzzola, A.Testa, G.Romeo,
B.Spoto, P.Zucchelli, C. Zoccali. The Angiotensin-Converting enzyme insertion /
depletion polymorphism is associated with nephroangiosclerosis. 35° EDTA-ERA
Congress,Rimini 6-9 Giugno 98.
39. F.Cuzzola, F.Mallamaci, C. Zoccali. Salt counter-reaction in hypertension: 24h
ambulatory monitoring study. 35° EDTA-ERA Congress, Rimini 6-9 giugno 1998.
40. F.Conte, M.Salomone, A.Barraca, S.Di Giulio, F.Locatelli, G.Piccoli, A.Santoro,C.
Zoccali,G.Colasanti. Italian Dialysis and transplantation registry (RIDT): first
report. 35° EDTA-ERA Congress, Rimini 6-9 Giugno 1998.
41. G.Tripepi, F.Mallamaci, C. Zoccali. Autonomic Dysfunction in dialysis patients is
linked to nocturnal hypoxemia. 35° EDTA-ERA Congress, Rimini 6-9 Giugno
1998.
42. G. Enia, O. Marzolla, M. Garozzo, V. Candela, ML. Mannino, SA. Malara,
C.Martorano, A.Curatola, P.Scudo,C.Labate,C. Zoccali. Macroglossia in long term
dialysis survivors. 35° EDTA-ERA Congress, Rimini 6-9 Giugno 1998.
43. G.Enia,V.Panuccio, S.Parlongo, A.Biondo, D.Pustorino, C. Zoccali. Evaluating
adequacy in CAPD: a comparison between the standard batch method and 2
methods based on aliquots. 35° EDTA-ERA Congress, Rimini 6-9 Giugno 1998.
44. C. Zoccali, L.Malatino, F.A. Benedetto,G. Tripepi,F. Mallamaci, M. Garozzo,E.
Cottini, G. Giacone, F. Rapisarda, P.Fatuzzo,G. Bonanno,G. Seminara. Arterial
pressure detrminant of LVH in uremic patients. 17° Congresso Internazionale
Società dell’Ipertensione. Amsterdam 7-11 June (Abstract book pp S-185).
45. C. Zoccali, A.Zuccala', R. Gaggi, M. Misefari, F. Mallamaci,F. Cuzzola, A. Testa,
G.Romeo, B. Spoto, P. Zucchelli. The angiotensin-converting enzyme
insertion/deletion polymorphism is associated with nephroangiosclerosis. 17°
Congresso Internazionale Società
dell’Ipertensione. Amsterdam 7-11 June
(Abstract book pp 183).
46. L. Malatino,F.A. Benedetto, G. Tripepi, F. Mallamaci, C. Marino, M. Garozzo,
C. Zoccali et al. Blood pressure determinants of common carotid intima-media
thickness and diameter in uremic patients. 17° Congresso Internazionale Società
dell’Ipertensione. Amsterdam 7-11 June (Abstract book pp. S-188).
47. F.A. Benedetto,G. Tripepi,F. Mallamaci,C. Marino,M. Garozzo,L. Malatino,F.
Tasone, C.
Zoccali et al. Pulse pressure and malnutrition are the main
determinants of vacular damage in dialysis patients. 33° Meeting American
Society of Hypertension, S.Francisco 13-16 May 98. (Abstract book pp 202A).
48. C. Zoccali, G. Tripepi, F. Mallamaci, V. Panuccio, M. Garozzo, S. Cutrupi, S.
Parlongo, C.Marino, L.Malatino, FA.Benedetto and CREED investigators. Creattive protein (CRP) and its relation to cardiovascular damage in dialysis
patients. 31° Meeting ASN. Philadelphia 25-28 October 1998.
49. C. Zoccali, G. Tripepi, F. Mallamaci, V. Panuccio, G. Enia, FA. Benedetto,
V.Candela, F. Tassone. Concentric hypertrophy is associated with nocturnal
hypoxemia in dialysis patients.31° Annual Meeting ASN. Philadelphia 25-28 Oct
1998.
50. C. Zoccali, F. Mallamaci, G. Tripepi. Nocturnal hypoxemia and dysautonomia in
dialysis patients. 31° Annual Meeting of ASN. Philadelphia, 25-28 Oct 1998.
51. G.Enia,V.Panuccio,S.Parlongo,S.Crucitti,
A.Biondo,D.Pustorino,C.
Zoccali.
Hypotensive effect of ultra-low sodium dialysate in CAPD patients: a double-bind
randomized, crossover study. 31st Annual Meeting of Am Soc Nephrology.
Philadelphia, 25-28 Oct 1998.
52. F.Mallamaci, G.Tripepi, F.Cuzzola, S.Cutrupi, S.Parlongo, C. Zoccali. Leptin is
raised indipendently of fat mass in essential hypertension. 31° Annual Meeting of
ASN. Philadelphia 25-28 Oct 1998.
53. F. Benedetto, G.Tripepi, C. Zoccali, G.Enia, F.Cambareri, M.Laface, V.Panuccio,
F. Mallamaci. Hypertension and nocturnal hypoxemia in chronic renal
failure.Twelfth Scientific Meeting Am Soc Hypert. S.Francisco, 27-31 Maggio
1997. (Am J Hyp 1997,10:192A).
54. F.Mallamaci, S.Parlongo, C. Zoccali. The influence of extracellular fluid volume on
plasma adrenomedullin in chronic renal failure. 8° European Meeting of
Hypertension, Milano, 13-16 Giugno 1997. (Abstract book pp S23).
55. F.Cuzzola, F.Mallamaci, C. Zoccali. Does salt alter day-night arterial pressure
excursion in essential hypertensives? Eight European Meeting on Hypertension.
Milano, 13-16 Giugno 1997. (Abstract book pag. S17).
56. F.Mallamaci, S.Parlongo, C. Zoccali. Volume dependence of Adrenomedullin
release in dialysis patients. 15° Annual Meeting of the International Society of
Blood Prurification, Firenze 11-13 Settembre 1997. (Blood Purification 1997,
15:2-3).
57. F. Cuzzola,F. Mallamaci,C. Zoccali. Does salt alter the day-night arterial pressure
excursion in essential hypertensives? 34° Congresso EDTA-ERA, Ginevra 21-24
Settembre 1997. (Abstract book pp. 61).
58. F. Mallamaci, G. Tripepi, F. Cuzzola, S. Cutrupi, S. Parlongo, C. Zoccali. Leptin,
the gene-product of ob gene, is markedly raised in haemodialysis patients. XXXIV
Congresso EDTA-ERA, Ginevra 21-24 Settembre 1997. (Abstract book pp. 113).
59. C. Zoccali, V. Misefari, G.Romeo, A. Testa, B. Spoto et al. Polymorphism of the
angiotensin I converting enzyme (ACE) gene do not predict disease progression,
nor response to ACE-inibities in diabetic chronic renal disease. 30° Annual
Meeting ASN, San Antonio,Texas, 2-5 November 97. (JASN Abstract pp. 80A).
60. P.Ruggenenti,A. Perna,C. Zoccali,Q. Maggiore et al. The angiotensin-convertingenzime(ACE) inhibitor ramipril slows the rate of GFR decline (GFR)and the
progression to end stage renal failure in proteinuric,non-diabetic chronic renal
diseases. 30° Annual Meeting ASN, San Antonio,Texas, 2-5 November 97. (JASN
Abstract pp.147A).
61. F.Mallamaci,G.Tripepi, F.Cuzzola, S.Cutrupi, S.Parlongo, C. Zoccali. The
relationship between leptin, the gene-product of ob gene and nutritional status in
hemodialysis patients. 30° Annual Meeting ASN, San Antonio,Texas, 2-5
November 97. (JASN Abstract pp.245A).
62. C. Zoccali,F. Cuzzola,F. Mallamaci,D. Leonardis. Salt counter-reactors in mild
hypertension: a reappraisal by 24h ambulatory monitoring. 30° Annual Meeting
ASN, San Antonio,Texas, 2-5 November 97. (JASN Abstract pp.325A).
63. C. Zoccali, G. Enia, G. Tripepi, F. Cambareri, M. Laface, V.Panuccio, F.Mallamaci.
Nocturnal hypoxemia alters the 24h arterial pressure profile in dialysis patients.
XXXIII Congresso EDTA-ERA, Amsterdam 18-21 Giugno 1996. (Nephrol Dial
Transplant [11, 6: A78,1996].
64. F.Mallamaci,S.Parlongo,C. Zoccali. Endothelin and the reflex circulatory control
in dialysis patients. XXXIII Congresso EDTA-ERA, Amsterdam 18-21 Giugno
1996. Nephrol Dial Transplant 11, 6: A207,1996].
65. M. Postorino,C. Marino, C. Zoccali and Registro Regionale Calabrese di dialisi e
Trapianto. Prevalence of major disabilities in the dialysis population. XXXIII
Congresso EDTA-ERA, Amsterdam 18-21 Giugno 1996. Nephrol Dial Transplant
[11, 6:A206, 1996].
66. M. Postorino,C. Marino,C. Zoccali and Reg. Reg. Cal. Dial. Trap. Performance of a
renal disease Severity Score (SS) in predicting hospedalisation an mortality in
dialysis patients. XXXIII Congresso EDTA-ERA, Amsterdam 18-21 Giugno 1996.
Nephrol Dial Transplant [11, 6:A206,1996].
67. M.Ciccarelli, C. Zoccali. A controlled trial comparing ultrafiltration (UF) at fixed
rate with non-linear ultrafiltration. XXXIII Congresso EDTA-ERA, Amsterdam 1821 Giugno 1996. Nephrol Dial Transplant [11, 6:A206,1996].
68. C. Zoccali, F.Mallamaci, G.Tripepi. Are dialysis patients predisposed to
vasodepressor syncope? Response to tilt testing. XXXIII Congresso EDTA-ERA,
Amsterdam 18-21 Giugno 1996. Nephrol.Dial. Tranplant. [11,6:A207,1996].
69. F. Mallamaci, S. Parlongo, C. Zoccali. Endothelin-1 (ET-1) in the Response to
Volume Depletion and Central Hypovolemia in Uraemic Patients on Chronic
Hemodialysis. 16° Meeting of the International Society of Hypertension. Glasgow
23-27 June 1996. (Abstract book pp. S67).
70. C. Zoccali, F.Mallamaci, D. Leonardis, F. Cuzzola. Reproducibility of the 24h
arterial pressure response to changes in salt intake in mild essential
hypertension. 16° Meeting of International Society of Hypertension. Glasgow 2327 June 1996. (Abstract book pp. S147).
71. F.Mallamaci, G.Tripepi, C. Zoccali. Vasodepressor syncope in haemodialysis
patients. 16° Meeting of International Society of Hypertension. Glasgow 23-27
June 1996. (Abstract book pp. S45).
72. C. Zoccali, G.Enia, G. Tripepi, F. Cambareri, V. Panuccio, F.Mallamaci.Nocturnal
hypertension and hypoxemia in dialysis patients. 29° Annual Meeting American
Society of Nephrology. New Orleans 3-6 Novembre 1996. (JASN 1996, 7(9):1529).
73. F.Mallamaci, G.Tripepi, C. Zoccali. The alarm reaction to blood pressure
measurement in uraemic patients on RDT. XXXII Congress EDTA-ERA Atene.
Nephrol Dial Tranplant 1995, 10:949.
74. F.Mallamaci, C. Zoccali, S.Parlongo, M.Postorino, L.Messineo. Acute changes in
extracellular volume and central blood volume influence plasma PTH 1-84
concentration in dialysis patients. XXXII Congresso EDTA-ERA Atene. Nephrol
Dial Tranplant 1995,10:1017.
75. C. Zoccali, G.Tripepi, V.Panuccio, S.Malara, C.Labate. Is sympathetic withdrawal
the main cause of dialysis hypotension? XXXII Congresso EDTA-ERA Atene.
Nephrol Dial Transplant 1995,10:1029.
76. F.Mallamaci, G.Tripepi, C. Zoccali. Persistence of the alerting reaction and rise in
blood pressure during measurement in uremic patient on RDT. 28° Annual
Meeting of American Society of Nephrology. San Diego 5-8 Novembre 1995. JASN
1995, 6:608.
77. F. Mallamaci, S. Parlongo, M. Postorino, C. Zoccali. Does circulating endothelin
partecipate in the volume-dependent arterial pressure control in dialysis patients?
28° Annual Meeting of American Society of Nephrology - San Diego 5-8 Novembre
1995. JASN 1995, 6:608.